The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test

European Journal of Pharmacology

Volumn 650, Issue 1, 2011, Pages 249-255

  Isacson, Ruben ^a   Nielsen, Elisabet ^a   Dannaeus, Karin ^a   Bertilsson, Göran ^a   Patrone, Cesare ^a   Zachrisson, Olof ^a   Wikström, Lilian ^a  

^a NeuroNova AB   (Sweden)

Author keywords

Cognition; Depression; Exendin 4; Glucagon like peptide 1 receptor; Hippocampus

Indexed keywords

BROXURIDINE; DOUBLECORTIN; E 7144; EXENDIN 4; IMIPRAMINE; KI 67 ANTIGEN; MESSENGER RNA; TRANSCRIPTION FACTOR MASH1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; DRUG MECHANISM; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPUS; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MALE; MAZE TEST; MOOD; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REFERENCE MEMORY; UPREGULATION;

AFFECT; ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; BROMODEOXYURIDINE; CELL DIFFERENTIATION; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; NEURONS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; SWIMMING; VENOMS;

EID: 78649745810     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.008     Document Type: Article

References (40)

1. E. Alvarez, M.D. Martínez, I. Roncero, J.A. Chowen, B. García-Cuartero, J.D. Gispert, C. Sanz, P. Vázquez, A. Maldonado, J. de Cáceres, M. Desco, M.A. Pozo, and E. Blázquez The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem J. Neurochem. 92 2005 798 806
2. G. Bertilsson, C. Patrone, O. Zachrisson, A. Andersson, K. Dannaeus, J. Heidrich, J. Kortesmaa, A. Mercer, E. Nielsen, H. Ronnholm, and L. Wikstrom Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease J. Neurosci. Res. 86 2008 326 338
3. M. Boldrini, M.D. Underwood, R. Hen, G.B. Rosoklija, A.J. Dwork, J. John Mann, and V. Arango Antidepressants increase neural progenitor cells in the human hippocampus Neuropsychopharmacology 34 2009 2376 2389
4. L. Brunetti, G. Orlando, L. Recinella, S. Leone, C. Ferrante, A. Chiavaroli, F. Lazzarin, and M. Vacca Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus Peptides 29 2008 1377 1381
5. J.A. Chowen, F.R. de Fonseca, E. Alvarez, M. Navarro, L.M. García-Segura, and E. Blázquez Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain Neuropeptides 33 1999 212 215
6. J.F. Cryan, and A. Holmes The ascent of mouse: advances in modelling human depression and anxiety Nat. Rev. Drug Discov. 4 2005 775 790
7. M.A. Curtis, M. Kam, U. Nannmark, M.F. Anderson, M.Z. Axell, C. Wikkelso, S. Holtas, W.M. van Roon-Mom, T. Bjork-Eriksson, C. Nordborg, J. Frisen, M. Dragunow, R.L. Faull, and P.S. Eriksson Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension Science 315 2007 1243 1249
8. A.B. Damholt, H. Kofod, and A.M. Buchan Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine Cell Tissue Res. 298 1999 287 293
9. M.J. During, L. Cao, D.S. Zuzga, J.S. Francis, H.L. Fitzsimons, X. Jiao, R.J. Bland, M. Klugmann, W.A. Banks, D.J. Drucker, and C.N. Haile Glucagon-like peptide-1 receptor is involved in learning and neuroprotection Nat. Med. 9 2003 1173 1179
10. J. Eng, W.A. Kleinman, L. Singh, G. Singh, and J.P. Raufman Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas J. Biol. Chem. 267 1992 7402 7405
11. P.S. Eriksson, E. Perfilieva, T. Bjork-Eriksson, A.M. Alborn, C. Nordborg, D.A. Peterson, and F.H. Gage Neurogenesis in the adult human hippocampus Nat. Med. 4 1998 1313 1317
12. V.A. Gault, and C. Holscher GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid Eur. J. Pharmacol. 587 2008 112 117
13. M. Gil-Lozano, D. Pérez-Tilve, M. Alvarez-Crespo, A. Martís, A.M. Fernandez, P.A. Catalina, L.C. Gonzalez-Matias, and F. Mallo GLP-1(7-36)-amide and Exendin-4 stimulate the HPA axis in rodents and humans Endocrinology 151 2010 2629 2640
14. R. Goke, H.C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, and B. Goke Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells J. Biol. Chem. 268 1993 19650 19655
15. A. Hamilton, and C. Holscher Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system NeuroReport 20 2009 1161 1166
16. A. Harkavyi, A. Abuirmeileh, R. Lever, A.E. Kingsbury, C.S. Biggs, and P.S. Whitton Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease J. Neuroinflammation 5 2008 19
17. G.U. Hoglinger, P. Rizk, M.P. Muriel, C. Duyckaerts, W.H. Oertel, I. Caille, and E.C. Hirsch Dopamine depletion impairs precursor cell proliferation in Parkinson disease Nat. Neurosci. 7 2004 726 735
18. I. Imayoshi, M. Sakamoto, T. Ohtsuka, K. Takao, T. Miyakawa, M. Yamaguchi, K. Mori, T. Ikeda, S. Itohara, and R. Kageyama Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain Nat. Neurosci. 11 2008 1153 1161
19. W. Jiang, Y. Zhang, L. Xiao, J. Van Cleemput, S.P. Ji, G. Bai, and X. Zhang Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects J. Clin. Invest. 115 2005 3104 3116
20. A.J. Kastin, V. Akerstrom, and W. Pan Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier J. Mol. Neurosci. 18 2002 7 14
21. A.J. Kastin, and V. Akerstrom Entry of exendin-4 into brain is rapid but may be limited at high doses Int. J. Obes. Relat. Metab. Disord. 27 2003 313 318
22. T.J. Kieffer, and J.F. Habener The glucagon-like peptides Endocr. Rev. 20 1999 876 913
23. S. Kim, M. Moon, and S. Park Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease J. Endocrinol. 202 2009 431 439
24. P.J. Larsen, M. Tang-Christensen, J.J. Holst, and C. Orskov Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem Neuroscience 77 1997 257 270
25. J.F. List, and J.F. Habener Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells Am. J. Physiol. Endocrinol. Metab. 286 2004 E875 881
26. P.M. Lledo, M. Alonso, and M.S. Grubb Adult neurogenesis and functional plasticity in neuronal circuits Nat. Rev. Neurosci. 7 2006 179 193
27. B. Martin, E. Golden, O.D. Carlson, P. Pistell, J. Zhou, W. Kim, B.P. Frank, S. Thomas, W.A. Chadwick, N.H. Greig, G.P. Bates, K. Sathasivam, M. Bernier, S. Maudsley, M.P. Mattson, and J.M. Egan Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease Diabetes 58 2009 318 328
28. D. Olton, and R.J. Samuelson Remembrance of places passed: spatial memory in rats J. Exp. Psychol. Anim. Behav. Process. 2 1976 97 116
29. T. Perry, N.J. Haughey, M.P. Mattson, J.M. Egan, and N.H. Greig Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4 J. Pharmacol. Exp. Ther. 302 2002 881 888
30. T. Perry, D.K. Lahiri, D. Chen, J. Zhou, K.T. Shaw, J.M. Egan, and N.H. Greig A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells J. Pharmacol. Exp. Ther. 300 2002 958 966
31. T. Perry, D.K. Lahiri, K. Sambamurti, D. Chen, M.P. Mattson, J.M. Egan, and N.H. Greig Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron J. Neurosci. Res. 72 2003 603 612
32. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. Thér. 229 1977 327 336
33. D. Russell-Jones The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes Int. J. Clin. Pract. 64 2010 1402 1414
34. A. Sahay, and R. Hen Adult hippocampal neurogenesis in depression Nat. Neurosci. 10 2007 1110 1115
35. A. Tashiro, H. Makino, and F.H. Gage Experience-specific functional modification of the dentate gyrus through adult neurogenesis: a critical period during an immature stage J. Neurosci. 27 2007 3252 3259
36. M. Tauchi, R. Zhang, D.A. D'Alessio, R.J. Seeley, and J.P. Herman Role of central glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilitation following chronic stress Exp. Neurol. 210 2008 458 566
37. H. van Praag, G. Kempermann, and F.H. Gage Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus Nat. Neurosci. 2 1999 266 270
38. J.L. Warner-Schmidt, and R.S. Duman Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment Hippocampus 16 2006 239 249
39. R. Zhang, B.A. Packard, M. Tauchi, D.A. D'Alessio, and J.P. Herman Glucocorticoid regulation of preproglucagon transcription and RNA stability during stress Proc. Natl Acad. Sci. USA 7 2009 5913 5918
40. C. Zhao, W. Deng, and F.H. Gage Mechanisms and functional implications of adult neurogenesis Cell 132 2008 645 660